adagrasib alongside a needle, pills, and vials scattered on white table

Mirati’s Adagrasib Non-Small Cell Lung Cancer Treatment Approved

By Kristina Johnson |

Adagrasib is the newest inhibitor drug for the treatment of KRAS-G12C mutated non-small cell lung cancer has been approved by the FDA. Mirati Therapeutics brings adagrasib to the market as an oral drug to help late-stage NSCLC patient's prognosis.

Read More

Woman holding hand with cancer patient

What are the 5 Most Deadly Cancers?

By Madeline May |

The top 5 most deadly cancers among men and women include lung cancer, mesothelioma, colon cancer, breast cancer, and pancreatic cancer. Learn more about the deadliest cancers, their treatment options, and their causes.

Read More

Modern setting and one of the best cancer hospitals

10 Best Lung Cancer Hospitals

By Rachel Ernst |

With so many options available, it can be tough to know where and who to turn to when seeking care for lung cancer. Our list of the 10 best lung cancer hospitals can provide some guidance.

Read More

Doctor in lab attire looking into microscope during scheduled lung cancer clinical trials.

5 New Lung Cancer Clinical Trials for 2022

By Madeline May |

Clinical trials provide options for those diagnosed with serious conditions such as mesothelioma and lung cancer. We gathered 5 new lung cancer and mesothelioma clinical trials accepting patients in 2022.

Read More